Chemotherapeutic approaches to the treatment of the acquired immune deficiency syndrome (AIDS).
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000276:immunology; D000327:Adsorption; D000914:Antibodies, Viral / Q000276:immunology; D000956:Antigens, Viral / Q000276:immunology; D001312:Aurintricarboxylic Acid / Q000494:pharmacology / Q000627:therapeutic use; D017977:Deltaretrovirus / Q000201:enzymology / Q000235:genetics / Q000502:physiology; D003841:Deoxycytidine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D017245:Foscarnet; D005814:Genes, Viral; D006023:Glycoproteins / Q000378:metabolism; D006801:Humans; D007372:Interferons / Q000494:pharmacology / Q000627:therapeutic use; D008297:Male; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D012367:RNA, Viral / Q000235:genetics; D012192:Retroviridae Infections / Q000188:drug therapy; D018894:Reverse Transcriptase Inhibitors; D012254:Ribavirin / Q000494:pharmacology / Q000627:therapeutic use; D013498:Suramin / Q000494:pharmacology / Q000627:therapeutic use; D013936:Thymidine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D014158:Transcription, Genetic / Q000187:drug effects; D014764:Viral Proteins / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects; D016047:Zalcitabine; D015215:Zidovudine
D000914:Antibodies, Viral; D000956:Antigens, Viral; D006023:Glycoproteins; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors; D014764:Viral Proteins; D003841:Deoxycytidine; D017245:Foscarnet; D001312:Aurintricarboxylic Acid; D012254:Ribavirin; D015215:Zidovudine; D013498:Suramin; D016047:Zalcitabine; D007372:Interferons; D010746:Phosphonoacetic Acid; D013936:Thymidine